Q1 2024 Holdings
Filed 2024-05-15 | 72 holdings | $252.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Vera Therapeutics Inc(VERA) | CL A | 92337R101 | $30.6M | 710,000 | 12.1% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $15.0M | 348,000 | 5.9% |
| Viking Therapeutics IncPut | PUT | 92686J956 | $14.4M | 175,300 | 5.7% |
| Advisorshares TRCall | CALL | 00768Y903 | $11.3M | 1,125,000 | 4.5% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $11.0M | 138,000 | 4.4% |
| Adma Biologics Inc(ADMA) | COM | 000899104 | $10.2M | 1,540,000 | 4.0% |
| Alimera Sciences Inc | COM NEW | 016259202 | $9.9M | 2,550,000 | 3.9% |
| Avadel Pharmaceuticals PLC | SPONSORED ADR | 05337M104 | $9.3M | 553,057 | 3.7% |
| Xtant MED Hldgs Inc(XTNT) | COM NEW | 98420P308 | $8.9M | 7,647,873 | 3.5% |
| Catalyst Pharmaceuticals Inc(CPRX) | COM | 14888U101 | $8.0M | 500,000 | 3.2% |
| Intra-Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $7.8M | 113,000 | 3.1% |
| Biohaven LTD(BHVN) | COM | G1110E107 | $7.7M | 140,000 | 3.0% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $7.0M | 85,000 | 2.8% |
| Olema Pharmaceuticals Inc(OLMA) | COM | 68062P106 | $6.8M | 605,000 | 2.7% |
| Savara Inc(SVRA) | COM | 805111101 | $6.6M | 1,335,000 | 2.6% |
| Soleno Therapeutics Inc(SLNO) | COM | 834203309 | $6.5M | 152,909 | 2.6% |
| Cybin Inc(CYBNEUR) | COM | 23256X100 | $5.8M | 13,953,488 | 2.3% |
| Oric Pharmaceuticals Inc(ORIC) | COM | 68622P109 | $5.6M | 405,000 | 2.2% |
| Larimar Therapeutics Inc(LRMR) | COM | 517125100 | $5.3M | 695,000 | 2.1% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $5.2M | 208,000 | 2.1% |
| Neurogene Inc(NGNE) | COM | 64135M105 | $5.1M | 100,000 | 2.0% |
| Praxis Precision Medicines I(PRAX) | COM NEW | 74006W207 | $4.8M | 78,100 | 1.9% |
| Achieve Life Sciences Inc(ACHV) | COM | 004468500 | $3.8M | 835,470 | 1.5% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $3.8M | 25,000 | 1.5% |
| Longboard Pharmaceuticals in | COM | 54300N103 | $3.7M | 170,000 | 1.5% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $3.3M | 120,000 | 1.3% |
| The Realreal Inc(REAL) | COM | 88339P101 | $3.1M | 800,000 | 1.2% |
| Alpine Immune Sciences Inc(NVLSEUR) | COM | 02083G100 | $3.1M | 77,848 | 1.2% |
| Boundless BIO Inc(BOLD) | COM | 10170A100 | $2.9M | 200,000 | 1.1% |
| Aquestive Therapeutics Inc(AQST) | COM | 03843E104 | $2.8M | 665,000 | 1.1% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $2.5M | 57,271 | 1.0% |
| Milestone Pharmaceuticals in(MIST) | COM | 59935V107 | $2.2M | 1,212,882 | 0.9% |
| Astria Therapeutics Inc(CATBUSD) | COM | 04635X102 | $2.0M | 142,532 | 0.8% |
| Zevra Therapeutics Inc(ZVRA) | COM NEW | 488445206 | $2.0M | 341,461 | 0.8% |
| Rapt Therapeutics IncCall | CALL | 75382E909 | $1.8M | 200,000 | 0.7% |
| Marinus Pharmaceuticals Inc(MRNS*) | COM NEW | 56854Q200 | $1.6M | 176,840 | 0.6% |
| Biovie Inc | CL A NEW | 09074F207 | $1.6M | 3,012,608 | 0.6% |
| Tourmaline BIO Inc(TRML) | COM | 89157D105 | $1.5M | 65,442 | 0.6% |
| Veru Inc(VERUEUR) | COM | 92536C103 | $1.5M | 2,111,731 | 0.6% |
| Geron CorpCall | CALL | 374163903 | $1.3M | 400,000 | 0.5% |
| Karyopharm Therapeutics Inc(KPTIEUR) | COM | 48576U106 | $1.1M | 740,000 | 0.4% |
| FAT Brands Inc | *W EXP 07/16/202 | 30258N121 | $974.0K | 200,000 | 0.4% |
| Spruce Biosciences Inc | COM | 85209E109 | $903.8K | 1,150,000 | 0.4% |
| Perspective Therapeutics Inc | COM | 46489V104 | $637.4K | 535,657 | 0.3% |
| Evoke Pharma Inc(EVOKEUR) | COM NEW | 30049G203 | $442.2K | 724,942 | 0.2% |
| Perfect Moment LTD(PMNT) | COM SHS | 713715100 | $330.1K | 92,208 | 0.1% |
| Rocket Pharmaceuticals Inc | *W EXP 09/02/202 | 77313F114 | $218.9K | 731,561 | 0.1% |
| Nexgel Inc | *W EXP 12/01/202 | 65344E115 | $162.0K | 225,000 | 0.1% |
| Mobilicom LTD | SPON ADS | 60742B102 | $161.0K | 135,292 | 0.1% |
| GRI BIO Inc | COM NEW | 3622AW205 | $142.9K | 187,981 | 0.1% |